SIGNIFICANCE OF C-ERBB-2 AND C-MYC ONCOGENE EXPRESSION FOR PROGNOSIS IN OVARIAN-CANCER

被引:0
作者
TANNER, B
FRIEDBERG, T
MITZE, M
KNAPSTEIN, PG
机构
[1] Universitäts-Frauenklinik Mainz, Mainz, D-55131
关键词
D O I
10.1007/BF02266249
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:946 / 948
页数:3
相关论文
共 4 条
[1]   C-MYC AMPLIFICATION IN OVARIAN-CANCER [J].
BAKER, VV ;
BORST, MP ;
DIXON, D ;
HATCH, KD ;
SHINGLETON, HM ;
MILLER, D .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :340-342
[2]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[3]  
MEDEN H, IN PRESS GEBURTSH FR, V52
[4]   STUDIES OF THE HER-2/NEU PROTO-ONCOGENE IN HUMAN-BREAST AND OVARIAN-CANCER [J].
SLAMON, DJ ;
GODOLPHIN, W ;
JONES, LA ;
HOLT, JA ;
WONG, SG ;
KEITH, DE ;
LEVIN, WJ ;
STUART, SG ;
UDOVE, J ;
ULLRICH, A ;
PRESS, MF .
SCIENCE, 1989, 244 (4905) :707-712